Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tanotnon Tanawattanasuntorn"'
Autor:
Sakulrat Mankhong, Thittaya Den-Udom, Tanotnon Tanawattanasuntorn, Thunwarat Suriyun, Kenjiro Muta, Chagriya Kitiyakara, Pimonrat Ketsawatsomkron
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Increased protein-bound uremic toxins (PBUTs) in patients with chronic kidney disease (CKD) are associated with cardiovascular diseases (CVDs); however, whether retention of PBUTs causes CVD remains unclear. Previous studies assessing the im
Externí odkaz:
https://doaj.org/article/8bf9274c8db14364962a1926b08c4a8c
Autor:
Tanotnon Tanawattanasuntorn, Tienthong Thongpanchang, Thanyada Rungrotmongkol, Chonnikan Hanpaibool, Potchanapond Graidist, Varomyalin Tipmanee
Publikováno v:
ACS Omega, Vol 6, Iss 1, Pp 606-614 (2020)
Externí odkaz:
https://doaj.org/article/50bf860425674b0e90e9595ee35d6675
Autor:
Tanotnon Tanawattanasuntorn, Thidarath Rattanaburee, Tienthong Thongpanchang, Potchanapond Graidist
Publikováno v:
Antioxidants, Vol 11, Iss 12, p 2347 (2022)
Synthetic trans-(±)-kusunokinin ((±)KU), a potential anticancer substance, was revealed to have an inhibitory effect on breast cancer. According to the computational modeling prediction, AKR1B1, an oxidative stress and cancer migration protein, cou
Externí odkaz:
https://doaj.org/article/8d14bdce8fc74a1da60d3a5cde5ba3b8
Autor:
Thidarath Rattanaburee, Tanotnon Tanawattanasuntorn, Tienthong Thongpanchang, Varomyalin Tipmanee, Potchanapond Graidist
Publikováno v:
Molecules, Vol 26, Iss 15, p 4537 (2021)
Trans-(−)-kusunokinin, an anticancer compound, binds CSF1R with low affinity in breast cancer cells. Therefore, finding an additional possible target of trans-(−)-kusunokinin remains of importance for further development. Here, a computational st
Externí odkaz:
https://doaj.org/article/328a8f3227614b63a9db6c83dba987d7
Autor:
Varomyalin Tipmanee, Thanyada Rungrotmongkol, Tienthong Thongpanchang, Chonnikan Hanpaibool, Tanotnon Tanawattanasuntorn, Potchanapond Graidist
Publikováno v:
ACS Omega, Vol 6, Iss 1, Pp 606-614 (2020)
ACS Omega
ACS Omega
(−)-Kusunokinin performed its anticancer potency through CFS1R and AKT pathways. Its ambiguous binding target has, however, hindered the next development phase. Our study thus applied molecular docking and molecular dynamics simulation to predict t
Autor:
Nadeeya, Mad-Adam, Thidarath, Rattanaburee, Tanotnon, Tanawattanasuntorn, Potchanapond, Graidist
Publikováno v:
Oncology Letters
Ovarian cancer ranks eighth in cancer incidence and mortality among women worldwide. Cisplatin-based chemotherapy is commonly used for patients with ovarian cancer. However, the clinical efficacy of cisplatin is limited due to the occurrence of adver
Autor:
Thidarath Rattanaburee, Tienthong Thongpanchang, Varomyalin Tipmanee, Potchanapond Graidist, Tanotnon Tanawattanasuntorn
Publikováno v:
Molecules
Volume 26
Issue 15
Molecules, Vol 26, Iss 4537, p 4537 (2021)
Volume 26
Issue 15
Molecules, Vol 26, Iss 4537, p 4537 (2021)
Trans-(−)-kusunokinin, an anticancer compound, binds CSF1R with low affinity in breast cancer cells. Therefore, finding an additional possible target of trans-(−)-kusunokinin remains of importance for further development. Here, a computational st